Company Filing History:
Years Active: 2017
Title: Estelle Bettelli: Innovator in Immunology
Introduction
Estelle Bettelli is a prominent inventor based in Newcastle, WA (US). She has made significant contributions to the field of immunology, particularly in the modulation and identification of human T17 cells. Her innovative work has implications for understanding immune responses and potential therapeutic applications.
Latest Patents
Estelle Bettelli holds a patent titled "Selective differentiation, identification, and modulation of human TH17 cells." This patent outlines methods for modulating both the differentiation and activity of human T17 cells. Specifically, it describes how TGF-β and IL-21, along with their agonists and antagonists, can influence T17 cell differentiation. Furthermore, the patent details how the function of T17 cells can be modulated by agents such as BLT1 or podoplanin, and their respective agonists and antagonists. The identification of T17 cells is also a key aspect of this patent, highlighting that these cells specifically upregulate BLT1 and podoplanin.
Career Highlights
Estelle Bettelli is affiliated with The Brigham and Women's Hospital, Inc., where she continues her research and innovation in immunology. Her work has garnered attention for its potential to advance the understanding of immune system functions and disorders.
Collaborations
Throughout her career, Estelle has collaborated with notable researchers, including Vijay K Kuchroo and David E Anderson. These collaborations have further enriched her research and contributed to advancements in the field.
Conclusion
Estelle Bettelli is a trailblazer in the field of immunology, with her patent on T17 cell modulation showcasing her innovative spirit. Her contributions are vital for future research and therapeutic developments in immunology.